Medical Laboratory Reagent Supply – Coagulation Testing Controls

The contract pertains to the supply of plasma control reagents specifically designed for citrated PT and APTT coagulation testing, ensuring compatibility with the NS 6630-01-519-3589 analyzer. These reagents must be maintained under strict refrigerated conditions throughout storage and shipment, with a required temperature range of 2–8°C to preserve stability and accuracy in diagnostic results. The reagents are critical for quality assurance in coagulation testing within a medical laboratory setting and must meet precise performance standards to support reliable clinical outcomes. This is a subcontract under the Medical Supply Chain MD SURG FSF, managed by the Department of Defense, with the place of performance located at JBER, Alaska, 99506-4400. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026. The NAICS code 325412 indicates classification within the pharmaceutical and medicine manufacturing sector, underscoring the technical and regulatory nature of the product. The contract is accessible via the DIBBS platform and requires vendors to meet stringent logistical and compliance requirements tied to defense medical supply operations.